Skip to main navigation
Skip to search
Skip to main content
Ben-Gurion University Research Portal Home
Help & FAQ
Home
Profiles
Research output
Research units
Prizes
Press/Media
Student theses
Projects
Activities
Datasets
Research Labs / Equipment
Search by expertise, name or affiliation
Curalin supplement as add-on therapy for type 2 diabetes Mellitus
Itamar Raz
, Roni Weinberg Sibony
, Saar Dor
, Aliza Rozenberg
, Ilan Yanuv
, Ofer Yigdal
, Ron Elul
, Omri Segev
Recanati School for Community Health Professions
Department of Epidemiology, Biostatistics and Community Health Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Curalin supplement as add-on therapy for type 2 diabetes Mellitus'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hemoglobin A1c (HbA1c)
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Add-on Therapy
100%
Placebo
60%
Antidiabetic Drugs
40%
Diabetes Treatment Satisfaction Questionnaire
40%
Placebo Groups
20%
Efficacy Endpoint
20%
Laboratory Results
20%
Mean Reduction
20%
Severe Adverse Events
20%
HbA1c Reduction
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hemoglobin A1c
100%
Add on Therapy
100%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
66%
Antidiabetic Agent
33%
Adverse Event
16%